Snapshot from Jul 05, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Jean Kaseya / Gilead Sciences

Jean Kaseya & Gilead Sciences

1 shared events · Importance 4 · Last updated Jun 30, 2026

Importance
4
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
75
International
Africa CDC Seeks Ebola Funding
Jean Kaseya: Dr. Jean Kaseya, Director General of the United States — Centers for Disease Control and Prevention, is a prominent voice in the urgent appeal for funding, emphasizing the critical need for immediate action to save lives.
Gilead Sciences: Gilead Sciences is a pharmaceutical company whose oral drug obeldesivir is being tested in the clinical trials to prevent Ebola infection. Its involvement highlights the private sector's role in developing countermeasures.
Jun 30, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how Jean Kaseya and Gilead Sciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.